|Articles|February 1, 2003

February 2003
Volume 9
Issue 2

When Depression is the Diagnosis, What Happens to Patients and Are They Satisfied?

Author(s)Leif I. Solberg, MD, Lucy Rose Fischer, PhD, William A. Rush, PhD

Download PDF: When Depression is the Diagnosis, What Happens to Patients and Are They Satisfied?

Articles in this issue

over 23 years ago

Article

Immunization Status Among Children Newly Enrolled in a Health Plan: A New Frontier for Quality Measurement?

over 23 years ago

Article

Healthcare Use by Veterans Treated for Diabetes Mellitus in the Veterans Affairs Medical Care System

over 23 years ago

Article

Medication Noncompliance in Patients With Chronic Disease: Issues in Dialysis and Renal Transplantation

over 23 years ago

Article

Restoring Trust to Managed Care, Part 1: A Focus on Patients

over 23 years ago

Article

STD Prevention and Treatment Guidelines: A Review from a Managed Care Perspective

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

When Depression is the Diagnosis, What Happens to Patients and Are They Satisfied?

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

Fifth Death Confirmed in NYC Legionnaires' Outbreak

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%

Small Workflow Changes Close Big Gaps in CKM Screening

Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective